Mycobacterium gordonae pulmonary disease associated with a continuous positive airway pressure device

M A Assi1, J C Berg, W F Marshall

  • 1Department of Internal Medicine, Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Insights

Home-use respiratory devices like CPAP machines lack cleaning guidelines. A kidney transplant patient contracted Mycobacterium gordonae pneumonia, likely from his CPAP device, highlighting a potential infection risk.

Area of Science:

  • Infectious Diseases
  • Nephrology
  • Pulmonology

Background:

  • Formal guidelines for the decontamination of home-use respiratory devices are absent.
  • Continuous positive airway pressure (CPAP) machines are commonly used for respiratory conditions.
  • Immunocompromised patients, such as kidney transplant recipients, are at higher risk for opportunistic infections.

Observation:

  • A kidney transplant recipient developed pneumonia.
  • The causative agent was identified as Mycobacterium gordonae.
  • The patient utilized a continuous positive airway pressure (CPAP) machine for respiratory support.

Findings:

  • The case suggests a potential transmission route of Mycobacterium gordonae via a CPAP machine.
  • Inadequate decontamination of respiratory devices may pose an infection risk to vulnerable populations.
  • This highlights a gap in patient safety protocols for home respiratory care.

Implications:

  • There is a critical need for standardized protocols on the cleaning and maintenance of home respiratory devices.
  • Healthcare providers should educate immunocompromised patients on the risks associated with CPAP use and proper device hygiene.
  • Further research is warranted to investigate the prevalence and prevention of device-associated infections in patients using respiratory support equipment.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...